deltatrials
Terminated OBSERVATIONAL NCT03118154

Efficacy of Manual Therapy to Improve Quality of Life and Decrease Pain in Subjects With Endometriosis (Endo2017)

Sponsor: Clear Passage Therapies, Inc

Updated 7 times since 2017 Last updated: Sep 22, 2017 Started: Mar 31, 2017 Primary completion: Oct 1, 2017 Completion: Mar 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment

Other terminated trials from Clear Passage Therapies, Inc

More terminations from Clear Passage Therapies, Inc

Other Dysmenorrhea trials with similar outcome

Browse all Dysmenorrhea trials

Listed as NCT03118154, this observational or N/A phase trial focuses on Dysmenorrhea and Endometriosis and remains terminated or withdrawn. Sponsored by Clear Passage Therapies, Inc, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2017 – ~Oct 2017 · 4 months · monthly snapshotRecruiting~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshotTerminated~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated

  5. Apr 2018 — Jun 2018 [monthly]

    Terminated

    Phase: NANone

Show 2 earlier versions
  1. Oct 2017 — Apr 2018 [monthly]

    Terminated NA

    Status: RecruitingTerminated

  2. Jun 2017 — Oct 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clear Passage Therapies, Inc
Data source: Clear Passage Therapies, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations